Background Atopic eczema (AE), also known as atopic dermatitis, is a chronic inflammatory
skin condition that causes significant burden. Phototherapy is sometimes used to treat AE …

Background Disease-specific studies have reported impaired humoral responses after
SARS-CoV-2 vaccination in patients with immune-mediated inflammatory disorders treated with …

Background Concerns have been raised regarding the risks of SARS-CoV-2 breakthrough
infections in vaccinated patients with immune-mediated inflammatory diseases treated with …

Background Studies have suggested incremental short-term adverse events (AE) after
repeated vaccination. In this report, we assessed occurrence and risk factors for short-term AEs …

Background The TREatment of ATopic eczema (TREAT) Registry Taskforce is a collaborative
international network of registries collecting data of atopic eczema (AE) patients receiving …

Objectives To compare the cumulative incidence and disease severity of reported SARS-CoV-2
omicron breakthrough infections between patients with immune-mediated inflammatory …

Background Despite multimodality limb salvage treatment (LST) for locally advanced
extremity soft tissue sarcoma (ESTS), some patients still need an amputation. Indications for …

For patients with immune-mediated inflammatory diseases (IMIDs), concerns exist about
increased disease activity after vaccination. We aimed to assess changes in disease activity …

SARS-CoV-2-specific CD8 + T cells recognize conserved viral peptides and in the absence
of cross-reactive antibodies form an important line of protection against emerging viral …

DEAR EDITOR, The BIOMarkers in Atopic dermatitis and Psoriasis (BIOMAP) is a large
European consortium aiming to advance personalized medicine for atopic dermatitis and …